# OR10A6

## Overview
OR10A6 is a gene that encodes the protein olfactory receptor family 10 subfamily A member 6, which is part of the G protein-coupled receptor (GPCR) superfamily. This receptor is primarily involved in olfactory signaling but has also been identified in non-olfactory tissues, such as human skin, where it plays a crucial role in epidermal differentiation and maintaining the skin's barrier function. The protein encoded by OR10A6 is a transmembrane receptor that participates in intracellular signaling pathways, influencing processes like keratinocyte differentiation and calcium regulation. While the gene has been associated with various clinical contexts, including cancer and medication adherence, its full range of functions and implications in human health and disease are still under investigation (Nakanishi2023Distinct; Barr2023Heritable; Nagayama2023Mutated).

## Function
OR10A6 is an olfactory receptor gene that is notably expressed in human skin tissue, where it plays a significant role in epidermal differentiation and the maintenance of the skin's water-impermeable barrier. This receptor is involved in keratinocyte function, contributing to processes such as keratinization, which is crucial for forming the protective outer layer of the skin (Nakanishi2023Distinct).

In keratinocytes, OR10A6 is associated with intracellular signaling pathways that regulate calcium concentration and ceramide production, both of which are important for skin barrier function and cell differentiation. The application of 3-phenylpropyl propionate (3PPP), an agonist of OR10A6, has been shown to increase intracellular calcium levels and enhance cornified envelope production, indicating its role in promoting keratinocyte differentiation (Nakanishi2023Distinct).

The receptor's activity is linked to specific signaling pathways, including those involving JNK1/2/3 and PLC-Î³1, which are implicated in keratinocyte differentiation and function. Knockdown experiments using siRNA have demonstrated that reducing OR10A6 expression diminishes these effects, underscoring its functional importance in skin biology (Nakanishi2023Distinct).

## Clinical Significance
The OR10A6 gene has been implicated in various clinical contexts, although its specific clinical significance is not well-documented. In the context of colorectal cancer (CRC), the OR10A6 gene was identified as having a higher binding affinity to HLA compared to other mutated genes. Despite this, it was not presented as a neoantigen peptide, suggesting that it may not activate the tumor immune response. This indicates that mutations in OR10A6 may be derived from immune-tolerant cancer cells, potentially contributing to cancer progression and recurrence by evading immune detection (Nagayama2023Mutated).

In a separate study on glaucoma medication non-adherence, a single nucleotide polymorphism (SNP) in the OR10A6 gene, rs4758258, was associated with a lower risk of non-adherence. This suggests a potential protective role of OR10A6 in medication adherence, although the study calls for further research to validate these findings in larger populations (Barr2023Heritable).

Overall, while OR10A6 has been linked to certain conditions, its precise role and clinical implications require further investigation to establish a comprehensive understanding.


## References


[1. (Nakanishi2023Distinct) Shinobu Nakanishi, Taiki Tsutsui, Nao Itai, and Mitsuhiro Denda. Distinct sets of olfactory receptors highly expressed in different human tissues evaluated by meta-transcriptome analysis: association of or10a6 in skin with keratinization. Frontiers in Cell and Developmental Biology, January 2023. URL: http://dx.doi.org/10.3389/fcell.2023.1102585, doi:10.3389/fcell.2023.1102585. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2023.1102585)

[2. (Barr2023Heritable) Julie L. Barr, Michael Feehan, Casey Tak, Leah A. Owen, Robert C. Finley, Parker A. Cromwell, John H. Lillvis, Patrice M. Hicks, Elizabeth Au, Michael H. Farkas, Asher Weiner, Andrew L. Reynolds, Sandra F. Sieminski, Richard M. Sherva, Mark A. Munger, Murray H. Brilliant, and Margaret M. DeAngelis. Heritable risk and protective genetic components of glaucoma medication non-adherence. International Journal of Molecular Sciences, 24(6):5636, March 2023. URL: http://dx.doi.org/10.3390/ijms24065636, doi:10.3390/ijms24065636. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24065636)

[3. (Nagayama2023Mutated) Satoshi Nagayama, Yuta Kobayashi, Mitsuko Fukunaga, Shotaro Sakimura, Keishi Sugimachi, Shin Sasaki, Takaaki Masuda, Ken-ichi Mafune, Masanobu Oshima, Tatsuhiro Shibata, Yutaka Suzuki, and Koshi Mimori. Mutated genes on ctdna detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases. Scientific Reports, January 2023. URL: http://dx.doi.org/10.1038/s41598-023-28575-3, doi:10.1038/s41598-023-28575-3. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-28575-3)